“…As a result, a total of 17 candidate target genes (including ATG12, ATg2B, ATg5, BCL9, BECN1, BNiP3L, CASP3, EZH2, gNAi2, gPR78, KPNB1, NoTCH1, RUNX2, SMAD1, SNAi1, SoCS1 and TP53) for which the interaction between miR-30d was validated experimentally by reporter assay, western blotting and qPCR, were collected from miRTarBase for miR-30d. Among these genes, a previous study of Esposito et al (10) found that miR-30d directly targeted the 3'-UTR of EZH2 in anaplastic thyroid carcinoma. Growing evidence also showed that EZH2 overexpression was associated with tumor aggressiveness and poor prognosis in patients with ESCC (16-18).…”